期刊文献+

Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia

原文传递
导出
摘要 Objective To explore the differences in safety and short-and long-term follow-up efficacy between humanized and murine CD19 CAR-T-cells for treating relapsed and refractory B-ALL.Methods Clinical data of 80 patients with R/R B-ALL treated with CD19-targeted CAR-Tcells at the Union Hospital of Tongji Medical College of Huazhong University of Science and Technology between May 2016 and March 2023 were analyzed.
作者 都孟仪 DU Mengyi(Instit Hematol,Union Hosp,Tongji Med Coll,Huazhong Univ Sci&Technol,Wuhan 430022)
机构地区 Instit Hematol
出处 《China Medical Abstracts(Internal Medicine)》 2024年第1期59-60,共2页 中国医学文摘(内科学分册(英文版)
关键词 CD19 CAR CLINICAL
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部